Bring your portfolio to life with these healthcare shares

I think that ageing populations, increased chronic disease burden, and growing populations make the healthcare sector a great place to invest with a long term view.

Three top healthcare shares that I think are amongst the best in the sector are listed below. Here’s why I would buy them:

CSL Limited (ASX: CSL)

I believe CSL is the best healthcare share on the Australian market and a great buy and hold option. Not only does the biopharmaceutical company have a strong core business and growing plasma collection network, it has a pipeline of drugs under development which could underpin its earnings growth over the next decade. Its shares may trade at a premium to the market average, but I believe its strong long term growth potential justifies this.

Nanosonics Ltd (ASX: NAN)

Another top healthcare share that I would consider buying is this infection control specialist. Nanosonics is the company behind the popular trophon EPR product which is used to clean ultrasound probes. The growing popularity of this product meant that in FY 2018 its total global installed base grew 25% to 17,740 units. I expect the release of its new trophon product to be a boost to its growth in FY 2019 and beyond, putting it in a great position to capture an increasing share of the overall market opportunity estimated to be 120,000 units globally.

Volpara Health Technologies Ltd (ASX: VHT)

Volpara is a healthcare technology company that can be found at the small end of the share market. It provides a breast imaging analytics and analysis software which has been increasing its share of the U.S. breast screening market at an impressive rate over the last 12 months. This led to the company reporting a significant jump in its annual recurring revenues. Based on its strong start to Fy 2019, I think Volpara is well-placed to continue its impressive run this year. Especially given its recent product enhancements.

Looking for more growth shares to invest in? Then check out these top mid cap shares that have been tipped for big things.

3 best mid cap growth shares to buy in 2019

We’re living in one of the most exciting times in investing history. Innovation and a booming culture of entrepreneurship are constantly creating new companies with the potential to make forward-thinking investors very rich. Now more than ever, one small, smart investment could make a huge difference to your wealth.

That’s why at The Motley Fool we’ve been scrutinizing the ASX to uncover the kinds of companies that we believe could turn into the next Atlassian.

We’ve found three exciting companies that we believe re poised to perform in the new year. Click here to uncover these ideas!

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited and VOLPARA FPO NZ. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!